Hollsteen
← VeriSign

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 2016: $171M · 10-Q 0001014473-17-000029 filed Jul 27, 2017Cash and equivalents · Q2 2016: $171M · 10-Q 0001014473-16-000111 filed Jul 28, 2016Cash and equivalents · Q3 2016: $178M · 10-Q 0001014473-16-000117 filed Oct 27, 2016Cash and equivalents · Q4 2016: $232M · 10-K 0001014473-17-000004 filed Feb 17, 2017Cash and equivalents · Q1 2017: $455M · 10-Q 0001014473-17-000012 filed Apr 27, 2017Cash and equivalents · Q2 2017: $242M · 10-Q 0001014473-17-000029 filed Jul 27, 2017Cash and equivalents · Q3 2017: $287M · 10-Q 0001014473-17-000048 filed Oct 26, 2017Cash and equivalents · Q4 2017: $466M · 10-K 0001014473-18-000018 filed Feb 16, 2018Cash and equivalents · Q1 2018: $1.7B · 10-Q 0001014473-18-000028 filed Apr 26, 2018Cash and equivalents · Q2 2018: $256M · 10-Q 0001014473-18-000036 filed Jul 26, 2018Cash and equivalents · Q3 2018: $232M · 10-Q 0001014473-18-000040 filed Oct 25, 2018Cash and equivalents · Q4 2018: $357M · 10-K 0001014473-19-000005 filed Feb 15, 2019Cash and equivalents · Q1 2019: $780M · 10-Q 0001014473-19-000015 filed Apr 25, 2019Cash and equivalents · Q2 2019: $752M · 10-Q 0001014473-19-000030 filed Jul 25, 2019Cash and equivalents · Q3 2019: $109M · 10-Q 0001014473-19-000037 filed Oct 24, 2019Cash and equivalents · Q4 2019: $508M · 10-K 0001014473-20-000006 filed Feb 14, 2020Cash and equivalents · Q1 2020: $499M · 10-Q 0001014473-20-000019 filed Apr 23, 2020Cash and equivalents · Q2 2020: $307M · 10-Q 0001014473-20-000029 filed Jul 23, 2020Cash and equivalents · Q3 2020: $146M · 10-Q 0001014473-20-000034 filed Oct 22, 2020Cash and equivalents · Q4 2020: $401M · 10-K 0001014473-21-000005 filed Feb 19, 2021Cash and equivalents · Q1 2021: $247M · 10-Q 0001014473-21-000015 filed Apr 22, 2021Cash and equivalents · Q2 2021: $216M · 10-Q 0001014473-21-000023 filed Jul 22, 2021Cash and equivalents · Q3 2021: $257M · 10-Q 0001014473-21-000027 filed Oct 28, 2021Cash and equivalents · Q4 2021: $224M · 10-K 0001014473-23-000005 filed Feb 17, 2023Cash and equivalents · Q1 2022: $758M · 10-Q 0001014473-22-000016 filed Apr 28, 2022Cash and equivalents · Q2 2022: $606M · 10-Q 0001014473-22-000023 filed Jul 28, 2022Cash and equivalents · Q3 2022: $561M · 10-Q 0001014473-22-000027 filed Oct 27, 2022Cash and equivalents · Q4 2022: $374M · 10-K 0001014473-23-000005 filed Feb 17, 2023Cash and equivalents · Q1 2023: $820M · 10-Q 0001014473-23-000019 filed Apr 27, 2023Cash and equivalents · Q2 2023: $344M · 10-Q 0001014473-23-000033 filed Jul 27, 2023Cash and equivalents · Q3 2023: $158M · 10-Q 0001014473-23-000038 filed Oct 26, 2023Cash and equivalents · Q4 2023: $240M · 10-K 0001014473-24-000006 filed Feb 15, 2024Cash and equivalents · Q1 2024: $732M · 10-Q 0001014473-24-000023 filed Apr 25, 2024Cash and equivalents · Q2 2024: $252M · 10-Q 0001014473-24-000033 filed Jul 25, 2024Cash and equivalents · Q3 2024: $267M · 10-Q 0001014473-24-000040 filed Oct 24, 2024Cash and equivalents · Q4 2024: $207M · 10-K 0001014473-25-000006 filed Feb 13, 2025Cash and equivalents · Q1 2025: $575M · 10-Q 0001014473-25-000021 filed Apr 24, 2025Cash and equivalents · Q2 2025: $314M · 10-Q 0001014473-25-000036 filed Jul 24, 2025Cash and equivalents · Q3 2025: $235M · 10-Q 0001014473-25-000046 filed Oct 23, 2025Cash and equivalents · Q4 2025: $308M · 10-K 0001014473-26-000006 filed Feb 5, 2026Cash and equivalents · Q1 2026: $477M · 10-Q 0001014473-26-000020 filed Apr 23, 2026Cash and equivalents · Q2 2026: $841M · 10-Q 0001014473-26-000028 filed Jul 23, 20262578411711,704Q1 2016Q2 2026Q3 2021
$MCash and equivalents · Q3 2020: $146M · 10-Q 0001014473-20-000034 filed Oct 22, 2020Cash and equivalents · Q4 2020: $401M · 10-K 0001014473-21-000005 filed Feb 19, 2021Cash and equivalents · Q1 2021: $247M · 10-Q 0001014473-21-000015 filed Apr 22, 2021Cash and equivalents · Q2 2021: $216M · 10-Q 0001014473-21-000023 filed Jul 22, 2021Cash and equivalents · Q3 2021: $257M · 10-Q 0001014473-21-000027 filed Oct 28, 2021Cash and equivalents · Q4 2021: $224M · 10-K 0001014473-23-000005 filed Feb 17, 2023Cash and equivalents · Q1 2022: $758M · 10-Q 0001014473-22-000016 filed Apr 28, 2022Cash and equivalents · Q2 2022: $606M · 10-Q 0001014473-22-000023 filed Jul 28, 2022257606146758Q3 2020Q2 2022Q3 2021
Q3 2021
257$M
All values (42)
PeriodValue ($M)Status
Q2 2026841reported
Q1 2026477reported
Q4 2025308reported
Q3 2025235reported
Q2 2025314reported
Q1 2025575reported
Q4 2024207reported
Q3 2024267reported
Q2 2024252reported
Q1 2024732reported
Q4 2023240reported
Q3 2023158reported
Q2 2023344reported
Q1 2023820reported
Q4 2022374reported
Q3 2022561reported
Q2 2022606reported
Q1 2022758reported
Q4 2021224reported
Q3 2021257reported
Q2 2021216reported
Q1 2021247reported
Q4 2020401reported
Q3 2020146reported
Q2 2020307reported
Q1 2020499reported
Q4 2019508reported
Q3 2019109reported
Q2 2019752reported
Q1 2019780reported
Q4 2018357reported
Q3 2018232reported
Q2 2018256reported
Q1 20181,704reported
Q4 2017466reported
Q3 2017287reported
Q2 2017242reported
Q1 2017455reported
Q4 2016232reported
Q3 2016178reported
Q2 2016171reported
Q1 2016171reported

CSV with all sources · Technical ID: cash

More metrics for VeriSign

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$257M
Period
Q3 2021, ended Sep 30, 2021 · as of Sep 30, 2021 (balance as of date, not a sum)
Source
10-Q, filed Oct 28, 2021 · 0001014473-21-000027
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$257MOct 28, 202110-Q 0001014473-21-000027reported · confidence 1. · current